NCT05209243View on ClinicalTrials.gov

START-MET HS Prostate Cancer. : SbrT & Androgen Receptor Therapy METastatic HSPC

NARecruitingINTERVENTIONAL
Enrollment

266

Participants

Timeline

Start Date

January 26, 2023

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2027

Conditions
Prostate CancerStereotactic Body Radiation Therapy
Interventions
RADIATION

SBRT

SBRT (all metastatic lesions)

RADIATION

STANDARD OF CARE

ADT+ RT to the primary tumor (previously not treated) + Second generation hormonal treatment

Trial Locations (2)

28034

RECRUITING

Hospital Universitario Ramón y Cajal, Madrid

Unknown

NOT_YET_RECRUITING

Hospital Universitari i Politècnic La Fe, Valencia

All Listed Sponsors
lead

Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic

OTHER